Comparison Between Polypyridyl and Cyclometalated Ruthenium(II) Complexes: Anticancer Activities Against 2D and 3D Cancer Models

2014 ◽  
Vol 21 (2) ◽  
pp. 715-725 ◽  
Author(s):  
Huaiyi Huang ◽  
Pingyu Zhang ◽  
Hongmin Chen ◽  
Liangnian Ji ◽  
Hui Chao
2018 ◽  
Vol 47 (43) ◽  
pp. 15312-15323 ◽  
Author(s):  
T. Srinivasa Reddy ◽  
Steven H. Privér ◽  
Vijay V. Rao ◽  
Nedaossadat Mirzadeh ◽  
Suresh K. Bhargava

Herein we report the synthesis of gold(i) and gold(iii) complexes of tris(4-methoxyphenyl)phosphine and tris(2,6-dimethoxyphenyl)phosphine and their anticancer activity towards 2D and 3D cancer models.


Molecules ◽  
2021 ◽  
Vol 26 (14) ◽  
pp. 4288
Author(s):  
Fernanda Malhão ◽  
Ana Catarina Macedo ◽  
Carla Costa ◽  
Eduardo Rocha ◽  
Alice Abreu Ramos

Fucoxanthin (Fx) is a carotenoid derived from marine organisms that exhibits anticancer activities. However, its role as a potential drug adjuvant in breast cancer (BC) treatment is still poorly explored. Firstly, this study investigated the cytotoxic effects of Fx alone and combined with doxorubicin (Dox) and cisplatin (Cis) on a panel of 2D-cultured BC cell lines (MCF7, SKBR3 and MDA-MB-231) and one non-tumoral cell line (MCF12A). Fucoxanthin induced cytotoxicity against all the cell lines and potentiated Dox cytotoxic effects towards the SKBR3 and MDA-MB-231 cells. The combination triggering the highest cytotoxicity (Fx 10 µM + Dox 1 µM in MDA-MB-231) additionally showed significant induction of cell death and genotoxic effects, relative to control. In sequence, the same combination was tested on 3D cultures using a multi-endpoint approach involving bioactivity assays and microscopy techniques. Similar to 2D cultures, the combination of Fx and Dox showed higher cytotoxic effects on 3D cultures compared to the isolated compounds. Furthermore, this combination increased the number of apoptotic cells, decreased cell proliferation, and caused structural and ultrastructural damages on the 3D models. Overall, our findings suggest Fx has potential to become an adjuvant for Dox chemotherapy regimens in BC treatment.


PLoS ONE ◽  
2013 ◽  
Vol 8 (10) ◽  
pp. e76373 ◽  
Author(s):  
Kyung Eun Sung ◽  
Xiaojing Su ◽  
Erwin Berthier ◽  
Carolyn Pehlke ◽  
Andreas Friedl ◽  
...  

2017 ◽  
Vol 393 ◽  
pp. 68-75 ◽  
Author(s):  
Alejandra Martinez de Pinillos Bayona ◽  
Josephine H. Woodhams ◽  
Hayley Pye ◽  
Rifat A. Hamoudi ◽  
Caroline M. Moore ◽  
...  

2017 ◽  
Vol 8 (21) ◽  
pp. 3317-3326 ◽  
Author(s):  
Jiacheng Zhao ◽  
Hongxu Lu ◽  
Sandy Wong ◽  
Mingxia Lu ◽  
Pu Xiao ◽  
...  

Enhanced cellular uptake and efficient penetration of nanocarriers inside tumors is paramount to successful anti-cancer therapy.


2020 ◽  
Vol 165 ◽  
pp. 1055-1065 ◽  
Author(s):  
Daniela V. Giacone ◽  
Vanessa F.M.C. Dartora ◽  
Jenyffer K.R. de Matos ◽  
Julia S. Passos ◽  
Daniel A.G. Miranda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document